Registrering av primära hjärntumörer mått på nationell vårdkvalitet: Regionala skillnader avslöjade

Lakartidningen

Volumn 104, Issue 5, 2007, Pages 332-341

  Bergenheim, Tommy ^a   Malmström, Annika ^b   Bolander, Hans ^c   Michanek, Annika ^d   Stragliotto, Giuseppe ^e   Damber, Lena ^f   Björ, Ove ^f   Henriksson, Roger ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f Båda Onkologiskt Centrum

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CLINICAL PRACTICE; DISEASE MANAGEMENT; GLIOMA; HEALTH CARE QUALITY; HUMAN; MIDDLE AGED; MORTALITY; OLIGODENDROGLIOMA; PROGNOSIS; REGISTER; SWEDEN; TIME;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE MANAGEMENT; GLIOMA; HUMANS; MIDDLE AGED; OLIGODENDROGLIOMA; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; SWEDEN; TIME FACTORS;

EID: 33846972004     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34: 45-60; discussion 60-1.
2. De Witte O, Levivier M, Violon P, Brotchi J, Goldman S. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery. 1998;43:398-9.
3. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro-oncol. 2004;6:227-35.
4. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190-8.
5. Kelly P, Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 1994;34:62-7.
6. Ampil F, Fowler M, Kookmin K. Intracranial astrocytoma in elderly patients. J Neurooncol. 1992;12:125-30.
7. Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G, et al. Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol. 2006;76:159-63.
8. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys. 1998;42:981-7.
9. Vives KP, Piepmeier JM. Complications and expected outcome of glioma surgery. J Neurooncol. 1999;42:289-302.
10. Brandes AA, Scelzi E, Salmistraro G, Ermani M, Carollo C, Berti F, et al. Incidence of risk of thromboembolism during treatment of high-grade gliomas: a prospective study. Eur J Cancer. 1997;33:1592-6.
11. Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H: Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J Neurooncol. 1992;14:119-25.
12. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003;98:1175-81.
13. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer. 2000;89:640-6.
14. Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M, et al. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology. 2003;65:259-66.
15. Fortin D, Macdonald DR, Stitt L, Cairncross JG. PCV for oligodendroglial tumors: in search of prognostic factors for response and survival. Can J Neurol Sci. 2001;28:215-23.
16. Zulch KJ. Historical development of the classification of brain tumours and the new proposal of the World Health Organization (WHO). Neurosurg Rev. 1981;4:123-7.
17. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64:479-89.
18. Keles GE, Anderson B, Berger MS. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol. 1999;52:371-9.
19. Albert FK, Forsting M. Resection and prognosis. J Neurosurg. 2003;98:225-6; author reply 226.